Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$45.73M
Net Profit Margin
-375.77%
TTM Avg
-226.26%
3Y Avg
-308.90%
5Y Avg
-527.22%
Market Cap
$47.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-9.50%
5Y Avg
-48.42%
Market Cap
$48.53M
Net Profit Margin
-128.69%
TTM Avg
-13664.85%
3Y Avg
-30726.86%
5Y Avg
-811138.03%
Market Cap
$44.72M
Net Profit Margin
-164.82%
TTM Avg
-1870.42%
3Y Avg
-1064.08%
5Y Avg
-709.38%
Market Cap
$44.71M
Net Profit Margin
32.60%
TTM Avg
-34.66%
3Y Avg
-64.33%
5Y Avg
-204.90%
Market Cap
$48.76M
Net Profit Margin
-4722.25%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$48.77M
Net Profit Margin
-51.53%
TTM Avg
-51.48%
3Y Avg
-72.44%
5Y Avg
-93.46%
Market Cap
$48.89M
Net Profit Margin
-88.45%
TTM Avg
-6.09%
3Y Avg
11.06%
5Y Avg
-1.98%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Instil Bio, Inc. (TIL) | $46.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Celularity Inc. (CELU)vs › | $45.73M | -375.77% | -226.26% | -308.90% | -527.22% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | 0.00% | 0.00% | -9.50% | -48.42% |
| Apollomics, Inc. (APLM)vs › | $48.53M | -128.69% | -13664.85% | -30726.86% | -811138.03% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -164.82% | -1870.42% | -1064.08% | -709.38% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 32.60% | -34.66% | -64.33% | -204.90% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | -4722.25% | 0.00% | 0.00% | 0.00% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | -51.53% | -51.48% | -72.44% | -93.46% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | -88.45% | -6.09% | 11.06% | -1.98% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -11.51% | -20.89% | -14.48% | -10.80% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | -13965.38% |
| 2020-06-30 | -21909.52% |
| 2020-03-31 | -9293.18% |
